PDB Short entry for 2V0Z HEADER HYDROLASE 21-MAY-07 2V0Z TITLE CRYSTAL STRUCTURE OF RENIN WITH INHIBITOR 10 (ALISKIREN) CAVEAT 2V0Z NAG C 1327 HAS WRONG CHIRALITY AT ATOM C1 NAG O 1328 HAS CAVEAT 2 2V0Z WRONG CHIRALITY AT ATOM C1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: RENIN; COMPND 3 CHAIN: C, O; COMPND 4 SYNONYM: ANGIOTENSINOGENASE; COMPND 5 EC: 3.4.23.15; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: CRICETULUS GRISEUS; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 10029; SOURCE 7 EXPRESSION_SYSTEM_CELL_LINE: CHO KEYWDS GLYCOPROTEIN, INHIBITOR-COMPLEX, ASPARTYL PROTEASE, ZYMOGEN, KEYWDS 2 PROTEASE, HYDROLASE, POLYMORPHISM, ALTERNATIVE SPLICING, KEYWDS 3 HYDROLASE(ACID PROTEINASE), CLEAVAGE ON PAIR OF BASIC RESIDUES EXPDTA X-RAY DIFFRACTION AUTHOR J.RAHUEL,V.RASETTI,J.MAIBAUM,H.RUEGER,R.GOSCHKE,N.C.COHEN,S.STUTZ, AUTHOR 2 F.CUMIN,W.FUHRER,J.M.WOOD,M.G.GRUTTER REVDAT 7 29-JUL-20 2V0Z 1 COMPND REMARK HETNAM LINK REVDAT 7 2 1 SITE REVDAT 6 03-APR-19 2V0Z 1 SOURCE LINK REVDAT 5 25-JUL-18 2V0Z 1 CAVEAT COMPND JRNL HET REVDAT 5 2 1 HETNAM LINK ATOM REVDAT 4 28-JUN-17 2V0Z 1 REMARK REVDAT 3 01-SEP-09 2V0Z 1 REMARK REVDAT 2 24-FEB-09 2V0Z 1 VERSN REVDAT 1 03-JUL-07 2V0Z 0 JRNL AUTH J.RAHUEL,V.RASETTI,J.MAIBAUM,H.RUEGER,R.GOSCHKE,N.C.COHEN, JRNL AUTH 2 S.STUTZ,F.CUMIN,W.FUHRER,J.M.WOOD,M.G.GRUTTER JRNL TITL STRUCTURE-BASED DRUG DESIGN: THE DISCOVERY OF NOVEL JRNL TITL 2 NONPEPTIDE ORALLY ACTIVE INHIBITORS OF HUMAN RENIN JRNL REF CHEM.BIOL. V. 7 493 2000 JRNL REFN ISSN 1074-5521 JRNL PMID 10903938 JRNL DOI 10.1016/S1074-5521(00)00134-4 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH J.RAHUEL,J.P.PRIESTLE,M.G.GRUTTER REMARK 1 TITL THE CRYSTAL STRUCTURES OF RECOMBINANT GLYCOSYLATED HUMAN REMARK 1 TITL 2 RENIN ALONE AND IN COMPLEX WITH A TRANSITION STATE ANALOG REMARK 1 TITL 3 INHIBITOR. REMARK 1 REF J.STRUCT.BIOL. V. 107 227 1991 REMARK 1 REFN ISSN 1047-8477 REMARK 1 PMID 1807356 REMARK 1 DOI 10.1016/1047-8477(91)90048-2 REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 40.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 97.0 REMARK 3 NUMBER OF REFLECTIONS : 0 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING SET) : 0.205 REMARK 3 FREE R VALUE : 0.266 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5190 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 106 REMARK 3 SOLVENT ATOMS : 685 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.011 REMARK 3 BOND ANGLES (DEGREES) : 2.030 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 25.87 REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2V0Z COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 21-MAY-07. REMARK 100 THE DEPOSITION ID IS D_1290032530. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-JAN-95 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 3.00 REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : ENRAF-NONIUS FR591 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MARXDS REMARK 200 DATA SCALING SOFTWARE : MARSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 46674 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 40.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.0 REMARK 200 DATA REDUNDANCY : 4.010 REMARK 200 R MERGE (I) : 0.06000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 61.25 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.17 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PH 3.00 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 3 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 5555 Z,X,Y REMARK 290 6555 Z+1/2,-X+1/2,-Y REMARK 290 7555 -Z+1/2,-X,Y+1/2 REMARK 290 8555 -Z,X+1/2,-Y+1/2 REMARK 290 9555 Y,Z,X REMARK 290 10555 -Y,Z+1/2,-X+1/2 REMARK 290 11555 Y+1/2,-Z+1/2,-X REMARK 290 12555 -Y+1/2,-Z,X+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 70.80000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 70.80000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 70.80000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 70.80000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 70.80000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 70.80000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY2 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY1 6 0.000000 0.000000 1.000000 70.80000 REMARK 290 SMTRY2 6 -1.000000 0.000000 0.000000 70.80000 REMARK 290 SMTRY3 6 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY1 7 0.000000 0.000000 -1.000000 70.80000 REMARK 290 SMTRY2 7 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 1.000000 0.000000 70.80000 REMARK 290 SMTRY1 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY2 8 1.000000 0.000000 0.000000 70.80000 REMARK 290 SMTRY3 8 0.000000 -1.000000 0.000000 70.80000 REMARK 290 SMTRY1 9 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 9 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY3 9 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY1 10 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 10 0.000000 0.000000 1.000000 70.80000 REMARK 290 SMTRY3 10 -1.000000 0.000000 0.000000 70.80000 REMARK 290 SMTRY1 11 0.000000 1.000000 0.000000 70.80000 REMARK 290 SMTRY2 11 0.000000 0.000000 -1.000000 70.80000 REMARK 290 SMTRY3 11 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY1 12 0.000000 -1.000000 0.000000 70.80000 REMARK 290 SMTRY2 12 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY3 12 1.000000 0.000000 0.000000 70.80000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: O REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASN C 160A REMARK 465 GLU O 160 REMARK 465 ASN O 160A REMARK 465 SER O 160B REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 SER C 159 CB OG REMARK 470 GLU C 160 CA C O CB CG CD OE1 REMARK 470 GLU C 160 OE2 REMARK 470 SER C 160B OG REMARK 470 GLN C 160C CB CG CD OE1 NE2 REMARK 470 SER O 159 CA C O CB OG REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 C SER O 160D N LEU O 161 1.33 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN C 67 -61.21 -137.47 REMARK 500 ARG C 157 39.30 -95.35 REMARK 500 GLN C 160C 54.03 -107.91 REMARK 500 ARG C 240 -166.67 -106.84 REMARK 500 ALA C 285 30.56 -84.17 REMARK 500 ASN O 67 -65.73 -133.17 REMARK 500 SER O 201 -16.72 -170.86 REMARK 500 ARG O 240 -92.01 -54.97 REMARK 500 PRO O 253 -5.37 -59.84 REMARK 500 LYS O 265 146.98 -171.04 REMARK 500 ALA O 285 31.03 -92.76 REMARK 500 MET O 289 118.41 -160.40 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: PLANAR GROUPS REMARK 500 REMARK 500 PLANAR GROUPS IN THE FOLLOWING RESIDUES HAVE A TOTAL REMARK 500 RMS DISTANCE OF ALL ATOMS FROM THE BEST-FIT PLANE REMARK 500 BY MORE THAN AN EXPECTED VALUE OF 6*RMSD, WITH AN REMARK 500 RMSD 0.02 ANGSTROMS, OR AT LEAST ONE ATOM HAS REMARK 500 AN RMSD GREATER THAN THIS VALUE REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI RMS TYPE REMARK 500 TYR O 267 0.06 SIDE CHAIN REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH C2016 DISTANCE = 6.56 ANGSTROMS REMARK 525 HOH C2017 DISTANCE = 7.64 ANGSTROMS REMARK 525 HOH C2018 DISTANCE = 7.26 ANGSTROMS REMARK 525 HOH C2059 DISTANCE = 8.28 ANGSTROMS REMARK 525 HOH C2129 DISTANCE = 6.39 ANGSTROMS REMARK 700 REMARK 700 SHEET REMARK 700 THE SHEET STRUCTURE OF THIS MOLECULE IS BIFURCATED. IN REMARK 700 ORDER TO REPRESENT THIS FEATURE IN THE SHEET RECORDS BELOW, REMARK 700 TWO SHEETS ARE DEFINED. REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1BBS RELATED DB: PDB REMARK 900 RENIN REMARK 900 RELATED ID: 1BIL RELATED DB: PDB REMARK 900 MOL_ID: 1; MOLECULE: RENIN; CHAIN: A, B; ENGINEERED: YES; HETEROGEN: REMARK 900 BUTANEDIAMIDE INHIBITOR BILA 1908; OTHER_DETAILS: GLYCOSYLATED REMARK 900 RELATED ID: 1BIM RELATED DB: PDB REMARK 900 MOL_ID: 1; MOLECULE: RENIN; CHAIN: A, B; ENGINEERED: YES; HETEROGEN: REMARK 900 BUTANEDIAMIDE INHIBITOR BILA 2151; OTHER_DETAILS: GLYCOSYLATED REMARK 900 RELATED ID: 1HRN RELATED DB: PDB REMARK 900 RENIN COMPLEXED WITH POLYHYDROXYMONOAMIDE INHIBITOR BILA 980 REMARK 900 RELATED ID: 1PR7 RELATED DB: PDB REMARK 900 RENIN COMPLEXED WITH COMPOUND IB REMARK 900 RELATED ID: 1PR8 RELATED DB: PDB REMARK 900 HUMAN RENIN COMPLEXED WITH A SUBSTITUTED PIPERIDINE REMARK 900 RELATED ID: 1RNE RELATED DB: PDB REMARK 900 RENIN (ACTIVATED, GLYCOSYLATED, INHIBITED) COMPLEX WITH CGP 38'560 REMARK 900 RELATED ID: 1UHQ RELATED DB: PDB REMARK 900 HUMAN RENIN COMPLEXED WITH A SUBSTITUTED PIPERIDINE REMARK 900 RELATED ID: 2BKS RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF RENIN-PF00074777 COMPLEX REMARK 900 RELATED ID: 2BKT RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF RENIN-PF00257567 COMPLEX REMARK 900 RELATED ID: 2G20 RELATED DB: PDB REMARK 900 KETOPIPERAZINE-BASED RENIN INHIBITORS: OPTIMIZATION OF THEC RING REMARK 900 RELATED ID: 2REN RELATED DB: PDB REMARK 900 RENIN REMARK 900 RELATED ID: 2V10 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF RENIN WITH INHIBITOR 9 REMARK 900 RELATED ID: 2V11 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF RENIN WITH INHIBITOR 6 REMARK 900 RELATED ID: 2V12 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF RENIN WITH INHIBITOR 8 REMARK 900 RELATED ID: 2V13 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF RENIN WITH INHIBITOR 7 REMARK 900 RELATED ID: 2V16 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF RENIN WITH INHIBITOR 3 DBREF 2V0Z C -5 326 UNP P00797 RENI_HUMAN 67 406 DBREF 2V0Z O -5 326 UNP P00797 RENI_HUMAN 67 406 SEQRES 1 C 340 LEU THR LEU GLY ASN THR THR SER SER VAL ILE LEU THR SEQRES 2 C 340 ASN TYR MET ASP THR GLN TYR TYR GLY GLU ILE GLY ILE SEQRES 3 C 340 GLY THR PRO PRO GLN THR PHE LYS VAL VAL PHE ASP THR SEQRES 4 C 340 GLY SER SER ASN VAL TRP VAL PRO SER SER LYS CYS SER SEQRES 5 C 340 ARG LEU TYR THR ALA CYS VAL TYR HIS LYS LEU PHE ASP SEQRES 6 C 340 ALA SER ASP SER SER SER TYR LYS HIS ASN GLY THR GLU SEQRES 7 C 340 LEU THR LEU ARG TYR SER THR GLY THR VAL SER GLY PHE SEQRES 8 C 340 LEU SER GLN ASP ILE ILE THR VAL GLY GLY ILE THR VAL SEQRES 9 C 340 THR GLN MET PHE GLY GLU VAL THR GLU MET PRO ALA LEU SEQRES 10 C 340 PRO PHE MET LEU ALA GLU PHE ASP GLY VAL VAL GLY MET SEQRES 11 C 340 GLY PHE ILE GLU GLN ALA ILE GLY ARG VAL THR PRO ILE SEQRES 12 C 340 PHE ASP ASN ILE ILE SER GLN GLY VAL LEU LYS GLU ASP SEQRES 13 C 340 VAL PHE SER PHE TYR TYR ASN ARG ASP SER GLU ASN SER SEQRES 14 C 340 GLN SER LEU GLY GLY GLN ILE VAL LEU GLY GLY SER ASP SEQRES 15 C 340 PRO GLN HIS TYR GLU GLY ASN PHE HIS TYR ILE ASN LEU SEQRES 16 C 340 ILE LYS THR GLY VAL TRP GLN ILE GLN MET LYS GLY VAL SEQRES 17 C 340 SER VAL GLY SER SER THR LEU LEU CYS GLU ASP GLY CYS SEQRES 18 C 340 LEU ALA LEU VAL ASP THR GLY ALA SER TYR ILE SER GLY SEQRES 19 C 340 SER THR SER SER ILE GLU LYS LEU MET GLU ALA LEU GLY SEQRES 20 C 340 ALA LYS LYS ARG LEU PHE ASP TYR VAL VAL LYS CYS ASN SEQRES 21 C 340 GLU GLY PRO THR LEU PRO ASP ILE SER PHE HIS LEU GLY SEQRES 22 C 340 GLY LYS GLU TYR THR LEU THR SER ALA ASP TYR VAL PHE SEQRES 23 C 340 GLN GLU SER TYR SER SER LYS LYS LEU CYS THR LEU ALA SEQRES 24 C 340 ILE HIS ALA MET ASP ILE PRO PRO PRO THR GLY PRO THR SEQRES 25 C 340 TRP ALA LEU GLY ALA THR PHE ILE ARG LYS PHE TYR THR SEQRES 26 C 340 GLU PHE ASP ARG ARG ASN ASN ARG ILE GLY PHE ALA LEU SEQRES 27 C 340 ALA ARG SEQRES 1 O 340 LEU THR LEU GLY ASN THR THR SER SER VAL ILE LEU THR SEQRES 2 O 340 ASN TYR MET ASP THR GLN TYR TYR GLY GLU ILE GLY ILE SEQRES 3 O 340 GLY THR PRO PRO GLN THR PHE LYS VAL VAL PHE ASP THR SEQRES 4 O 340 GLY SER SER ASN VAL TRP VAL PRO SER SER LYS CYS SER SEQRES 5 O 340 ARG LEU TYR THR ALA CYS VAL TYR HIS LYS LEU PHE ASP SEQRES 6 O 340 ALA SER ASP SER SER SER TYR LYS HIS ASN GLY THR GLU SEQRES 7 O 340 LEU THR LEU ARG TYR SER THR GLY THR VAL SER GLY PHE SEQRES 8 O 340 LEU SER GLN ASP ILE ILE THR VAL GLY GLY ILE THR VAL SEQRES 9 O 340 THR GLN MET PHE GLY GLU VAL THR GLU MET PRO ALA LEU SEQRES 10 O 340 PRO PHE MET LEU ALA GLU PHE ASP GLY VAL VAL GLY MET SEQRES 11 O 340 GLY PHE ILE GLU GLN ALA ILE GLY ARG VAL THR PRO ILE SEQRES 12 O 340 PHE ASP ASN ILE ILE SER GLN GLY VAL LEU LYS GLU ASP SEQRES 13 O 340 VAL PHE SER PHE TYR TYR ASN ARG ASP SER GLU ASN SER SEQRES 14 O 340 GLN SER LEU GLY GLY GLN ILE VAL LEU GLY GLY SER ASP SEQRES 15 O 340 PRO GLN HIS TYR GLU GLY ASN PHE HIS TYR ILE ASN LEU SEQRES 16 O 340 ILE LYS THR GLY VAL TRP GLN ILE GLN MET LYS GLY VAL SEQRES 17 O 340 SER VAL GLY SER SER THR LEU LEU CYS GLU ASP GLY CYS SEQRES 18 O 340 LEU ALA LEU VAL ASP THR GLY ALA SER TYR ILE SER GLY SEQRES 19 O 340 SER THR SER SER ILE GLU LYS LEU MET GLU ALA LEU GLY SEQRES 20 O 340 ALA LYS LYS ARG LEU PHE ASP TYR VAL VAL LYS CYS ASN SEQRES 21 O 340 GLU GLY PRO THR LEU PRO ASP ILE SER PHE HIS LEU GLY SEQRES 22 O 340 GLY LYS GLU TYR THR LEU THR SER ALA ASP TYR VAL PHE SEQRES 23 O 340 GLN GLU SER TYR SER SER LYS LYS LEU CYS THR LEU ALA SEQRES 24 O 340 ILE HIS ALA MET ASP ILE PRO PRO PRO THR GLY PRO THR SEQRES 25 O 340 TRP ALA LEU GLY ALA THR PHE ILE ARG LYS PHE TYR THR SEQRES 26 O 340 GLU PHE ASP ARG ARG ASN ASN ARG ILE GLY PHE ALA LEU SEQRES 27 O 340 ALA ARG MODRES 2V0Z ASN C 67 ASN GLYCOSYLATION SITE MODRES 2V0Z ASN O 67 ASN GLYCOSYLATION SITE HET NAG C1327 14 HET C41 C1328 39 HET C41 O1327 39 HET NAG O1328 14 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM C41 ALISKIREN FORMUL 3 NAG 2(C8 H15 N O6) FORMUL 4 C41 2(C30 H53 N3 O6) FORMUL 7 HOH *685(H2 O) HELIX 1 1 TYR C 47B HIS C 53 1 7 HELIX 2 2 ASP C 57 SER C 61 5 5 HELIX 3 3 PRO C 108 MET C 113 1 6 HELIX 4 4 PHE C 125 ALA C 129 5 5 HELIX 5 5 ALA C 129 VAL C 133 5 5 HELIX 6 6 PRO C 135 SER C 142 1 8 HELIX 7 7 ASP C 171 GLN C 173 5 3 HELIX 8 8 SER C 224 GLY C 236 1 13 HELIX 9 9 ASN C 250 LEU C 255 5 6 HELIX 10 10 THR C 270 VAL C 275 1 6 HELIX 11 11 GLY C 302 ARG C 307 1 6 HELIX 12 12 TYR O 47B HIS O 53 1 7 HELIX 13 13 ASP O 57 SER O 61 5 5 HELIX 14 14 PRO O 108 MET O 113 1 6 HELIX 15 15 PHE O 125 ALA O 129 5 5 HELIX 16 16 ALA O 129 VAL O 133 5 5 HELIX 17 17 PRO O 135 GLN O 143 1 9 HELIX 18 18 ASP O 171 HIS O 174 5 4 HELIX 19 19 SER O 224 GLY O 236 1 13 HELIX 20 20 ASN O 250 LEU O 255 5 6 HELIX 21 21 THR O 270 VAL O 275 1 6 HELIX 22 22 GLY O 302 LYS O 308 1 7 SHEET 1 CA 3 LYS C 65 TYR C 75 0 SHEET 2 CA 3 GLY C 78 VAL C 91 -1 O GLY C 78 N TYR C 75 SHEET 3 CA 3 GLN C 13 ILE C 20 -1 O GLY C 19 N THR C 90 SHEET 1 CB 7 LYS C 65 TYR C 75 0 SHEET 2 CB 7 GLY C 78 VAL C 91 -1 O GLY C 78 N TYR C 75 SHEET 3 CB 7 ILE C 94 GLU C 106 -1 O ILE C 94 N VAL C 91 SHEET 4 CB 7 VAL C 38 PRO C 41 1 O VAL C 38 N GLY C 102 SHEET 5 CB 7 GLY C 119 GLY C 122 -1 O VAL C 120 N TRP C 39 SHEET 6 CB 7 GLN C 25 ASP C 32 1 O VAL C 30 N VAL C 121 SHEET 7 CB 7 GLN C 13 ILE C 20 -1 O GLY C 16 N VAL C 29 SHEET 1 CC 3 GLN C 191 MET C 194 0 SHEET 2 CC 3 CYS C 210 VAL C 214 -1 O CYS C 210 N MET C 194 SHEET 3 CC 3 TRP C 299 LEU C 301 1 O TRP C 299 N LEU C 213 SHEET 1 CD 4 SER C 202 LEU C 205 0 SHEET 2 CD 4 GLY C 196 VAL C 199 -1 O VAL C 197 N LEU C 205 SHEET 3 CD 4 ILE C 258 LEU C 262 -1 O SER C 259 N SER C 198 SHEET 4 CD 4 LYS C 265 LEU C 269 -1 O LYS C 265 N LEU C 262 SHEET 1 CE 2 ILE C 221 GLY C 223 0 SHEET 2 CE 2 ILE C 286 ALA C 288 1 O HIS C 287 N GLY C 223 SHEET 1 CF 3 LYS C 238 LYS C 239 0 SHEET 2 CF 3 TYR C 245 LYS C 248 -1 O VAL C 246 N LYS C 238 SHEET 3 CF 3 LEU C 281D THR C 283 -1 O CYS C 282 N VAL C 247 SHEET 1 OA 3 LYS O 65 TYR O 75 0 SHEET 2 OA 3 GLY O 78 VAL O 91 -1 O GLY O 78 N TYR O 75 SHEET 3 OA 3 GLN O 13 ILE O 20 -1 O GLY O 19 N THR O 90 SHEET 1 OB 7 LYS O 65 TYR O 75 0 SHEET 2 OB 7 GLY O 78 VAL O 91 -1 O GLY O 78 N TYR O 75 SHEET 3 OB 7 ILE O 94 GLU O 106 -1 O ILE O 94 N VAL O 91 SHEET 4 OB 7 VAL O 38 PRO O 41 1 O VAL O 38 N GLY O 102 SHEET 5 OB 7 GLY O 119 GLY O 122 -1 O VAL O 120 N TRP O 39 SHEET 6 OB 7 GLN O 25 ASP O 32 1 O VAL O 30 N VAL O 121 SHEET 7 OB 7 GLN O 13 ILE O 20 -1 O GLY O 16 N VAL O 29 SHEET 1 OC 6 SER O 202 LEU O 205 0 SHEET 2 OC 6 GLN O 191 VAL O 199 -1 O VAL O 197 N LEU O 205 SHEET 3 OC 6 CYS O 210 VAL O 214 -1 O CYS O 210 N MET O 194 SHEET 4 OC 6 TRP O 299 LEU O 301 1 O TRP O 299 N LEU O 213 SHEET 5 OC 6 ILE O 221 GLY O 223 -1 O SER O 222 N ALA O 300 SHEET 6 OC 6 ILE O 286 ALA O 288 1 O HIS O 287 N GLY O 223 SHEET 1 OD 4 SER O 202 LEU O 205 0 SHEET 2 OD 4 GLN O 191 VAL O 199 -1 O VAL O 197 N LEU O 205 SHEET 3 OD 4 ILE O 258 LEU O 262 -1 O SER O 259 N SER O 198 SHEET 4 OD 4 GLU O 266 LEU O 269 -1 O TYR O 267 N PHE O 260 SHEET 1 OE 3 LYS O 238 LYS O 239 0 SHEET 2 OE 3 TYR O 245 LYS O 248 -1 O VAL O 246 N LYS O 238 SHEET 3 OE 3 LEU O 281D THR O 283 -1 O CYS O 282 N VAL O 247 SSBOND 1 CYS C 45 CYS C 50 1555 1555 2.03 SSBOND 2 CYS C 206 CYS C 210 1555 1555 2.03 SSBOND 3 CYS C 249 CYS C 282 1555 1555 2.03 SSBOND 4 CYS O 45 CYS O 50 1555 1555 2.03 SSBOND 5 CYS O 206 CYS O 210 1555 1555 2.04 SSBOND 6 CYS O 249 CYS O 282 1555 1555 2.04 LINK ND2 ASN C 67 C1 NAG C1327 1555 1555 1.46 LINK ND2 ASN O 67 C1 NAG O1328 1555 1555 1.45 CISPEP 1 THR C 22 PRO C 23 0 -0.46 CISPEP 2 LEU C 110 PRO C 111 0 0.29 CISPEP 3 PRO C 293 PRO C 294 0 0.02 CISPEP 4 GLY C 296 PRO C 297 0 0.02 CISPEP 5 THR O 22 PRO O 23 0 -0.12 CISPEP 6 LEU O 110 PRO O 111 0 0.34 CISPEP 7 PRO O 293 PRO O 294 0 -0.05 CISPEP 8 GLY O 296 PRO O 297 0 0.07 CRYST1 141.600 141.600 141.600 90.00 90.00 90.00 P 21 3 24 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007062 0.000000 0.000000 0.00000 SCALE2 0.000000 0.007062 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007062 0.00000